Antimicrobial therapy of community-acquired pneumonia (CAP) at an out-patient stage in the Samara region during the 5-year period

O. Sivakova, E. Petrovskaya (Samara, Russian Federation)

Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Session: Manifestations, scores and prognosis of community-acquired pneumonia
Session type: Thematic Poster Session
Number: 2760
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Sivakova, E. Petrovskaya (Samara, Russian Federation). Antimicrobial therapy of community-acquired pneumonia (CAP) at an out-patient stage in the Samara region during the 5-year period. Eur Respir J 2013; 42: Suppl. 57, 2760

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

5-year weekly monitoring of community-acquired pneumonia incidence and mortality
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016


Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014


Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Relation between the empiric initial therapy of S.pneumoniae community-acquired pneumonia (SP-CAP) and mortality in thirty days of outcome. On behalf of Pneumococcal Pneumonia Cooperative Study Group, Grupo TIR, SEPAR
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003


Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis
Source: Eur Respir J 2008; 31: 1068-1076
Year: 2008



Patterns of antibiotic prescribing for pneumonia at the outpatient to inpatient transition
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Relationship between the use of inhaled steroids and early outcomes in community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Epidemiology of community-acquired pneumonia (CAP)
Source: International Congress 2015 – Russia Day: Community-acquired pneumonia (CAP) in adults
Year: 2015



Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP)
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Prior antibiotics and outcomes in patients hospitalized with pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Optimizing treatment for community-acquired pneumonia in Denmark (The optiCAP study)
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Emergency treatment of communityacquired pneumonia
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=183
Year: 2006

Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals
Source: Eur Respir J 2005; 26: Suppl. 49, 638s
Year: 2005

Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014